Distribution Studies with Sulfur 35-Labeled Disulfonamides in Tumor-Bearing and Tumor-Free Mice
1958

Study of Sulfur-35 Labeled Disulfonamides in Mice

Sample size: 70 publication Evidence: moderate

Author Information

Author(s): MARY F. ARGUS, TREVA L. SEEPE, NORA GUTIERREZ, KATHLEEN HEWSON, FRANCIS E. RAY

Primary Institution: University of Florida

Hypothesis

Can sulfur-35 labeled disulfonamides localize in tumor tissue more effectively than in normal tissues?

Conclusion

Fluorene-2,7-di-(sulfonamidobenzene)-S35 showed the best tumor localization among the compounds tested.

Supporting Evidence

  • Fluorene-2,7-di-(sulfonamidobenzene)-S35 had the highest concentration in tumor tissue at 8 hours.
  • Biphenyl-4,4'-di-(sulfonamidobenzene-4-carboxylic acid)-S35 localized better in tumor tissue than in blood cells.
  • Biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) did not show selective tumor affinity.

Takeaway

The study tested new compounds to see if they could find tumors better than normal tissues, and one compound did a really good job.

Methodology

The study involved administering three sulfur-35 labeled disulfonamides to tumor-bearing and tumor-free mice and measuring their distribution in various tissues.

Limitations

The study only tested a limited number of compounds and relied on a specific mouse model.

Participant Demographics

Male CAF/Jax hybrid mice, some with transplanted tumors.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication